百济神州深陷亏损泥潭 2025年乐观预期增长能否实现?

电鳗快报
13 hours ago

在医药创新领域,百济神州作为一家致力于发现和开发创新性疗法的全球肿瘤创新公司,近年来一直备受瞩目。然而,其经营状况却引发了市场的广泛关注和讨论。自2017年至2024年,百济神州在过去的八年里累计亏损高达591亿元。从2019年至2023年以及2024年前三季度,该公司的归母净利润分别为-69.1亿元、-113.8亿元、-97.5亿元、-136.4亿元、-67.2亿元和-36.9亿元。尽管面临着...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10